TNF is here to stay - Revisited [2]

Trends in Immunology

Volumn 22, Issue 3, 2001, Pages 127-129

  Ten Hagen, Timo L M ^a   Eggermont, Alexander M M ^a   Lejeune, Ferdy J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOSTATIC AGENT; DOXORUBICIN; GAMMA INTERFERON; MELPHALAN; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; DOWN REGULATION; ENDOTHELIUM CELL; LETTER; LIMB PERFUSION; MELANOMA; NONHUMAN; SARCOMA; SOFT TISSUE SARCOMA; TUMOR CELL LINE;

EID: 0034924489     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(00)01850-0     Document Type: Letter

References (15)

1. TNF is here to stay!
2. Dual role of tumor necrosis factor-α in angiogenesis
3. High-dose recombinant tumor necrosis factor α in combination with interferon γ and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
4. Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial
5. Limb salvage by isolated limb perfusion (ILP) with TNF and melphalan in patients with locally advanced soft tissue sarcomas: Outcome of 270 ILPs in 246 patients
6. Prerequisites for effective isolated limb perfusion using tumour necrosis factor α and melphalan in rats
7. Synergistic effects of TNF-α and melphalan in an isolated limb perfusion model of rat sarcoma: A histopathological, immunohistochemical and electron microscopical study
8. TNF-α augments intratumoural concentrations of doxorubicin in TNF-α-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects
9. Tumour necrosis factor a increases melphalan concentration in tumour tissue after isolated limb perfusion
10. 3 in the disruption of the tumor vasculature induced by TNF and IFN-α
11. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts
12. Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats
13. Tumor vasculature as a target in the antitumor activity of tumor necrosis factor and interferon-γ
14. Isolated hypoxic hepatic perfusion with tumor necrosis factor-alpha, melphalan and mitomycin C using balloon catheter techniques: A pharmacokinetic study in pigs
15. Tumor necrosis factor-α augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model